[1]
“CURRENT DRUGS AND NEW THERAPEUTIC APPROACHES FOR THE LEISHMANIASIS TREATMENT”, ACBIOBRAS, vol. 2, nº 1, p. 80–100, jun. 2019, doi: 10.18554/acbiobras.v2i1.8655.